Steward Partners Investment Advisory, LLC Iovance Biotherapeutics, Inc. Transaction History
Steward Partners Investment Advisory, LLC
- $9.37 Billion
- Q2 2024
A detailed history of Steward Partners Investment Advisory, LLC transactions in Iovance Biotherapeutics, Inc. stock. As of the latest transaction made, Steward Partners Investment Advisory, LLC holds 10,997 shares of IOVA stock, worth $111,839. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,997
Previous 11,297
2.66%
Holding current value
$111,839
Previous $167,000
47.31%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding IOVA
# of Institutions
323Shares Held
239MCall Options Held
1.27MPut Options Held
1.68M-
Vanguard Group Inc Valley Forge, PA26MShares$264 Million0.0% of portfolio
-
Perceptive Advisors LLC New York, NY25.9MShares$264 Million6.02% of portfolio
-
Mhr Fund Management LLC New York, NY24MShares$244 Million28.39% of portfolio
-
Black Rock Inc. New York, NY21.2MShares$216 Million0.0% of portfolio
-
State Street Corp Boston, MA12.6MShares$128 Million0.0% of portfolio
About IOVANCE BIOTHERAPEUTICS, INC.
- Ticker IOVA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 157,800,992
- Market Cap $1.6B
- Description
- Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...